CO
₹481.35
+5.30(+1.11%)
COHANCE₹481.35+1.11%
Group Companies
Foreign Flows
sector level — not this stockHealthcare sector+₹2,114 Crnet foreign buying
2026-09-01 to 2026-09-15This is the flow into the whole Healthcare sector, not into COHANCE. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.
Supply Chain
suppliers and customers in the graphMacro Sensitivity
rates, currency, commoditiesRevenue by Segment
Business Group
Geographic Exposure
revenue, imports, currencyScenario analysis
stated assumptions, shown workingsCOHANCE exposure summary
Cohance Lifesciences Limited reports a single business segment, CONTRACT DEVELOPMENT AND MANUFACTURING. Cohance Lifesciences Limited is a constituent of 5 indices, with its largest weights in NIFTY Smallcap 100 (0.61%), S&P BSE 500 (0.04%), NIFTY 500 (0.04%).
| Index memberships | 5 |
|---|